The authors review anatomical, clinical characteristics and prevalence of thyroid microcarcinoma. Diagnostic procedures and risk factors of aggressiveness at diagnosis and during follow-up are also covered. The possible clinical, pathologic and therapeutic risk factors are analyzed by meta-analysis study. Treatment procedures by different authors and guidelines suggested by societies are reported.

Papillary thyroid microcarcinoma (PMC) is defined as a papillary carcinoma 1 cm or less in size. PMC is a variant of papillary carcinoma, the most common thyroid cancer, which has a very good prognosis and in which distant metastases and death (0.4--1% per year) are exceptional.1 We report a patient who was diagnosed with metastasis of a papillary microcarcinoma as the result of an evaluation o...

References Coughlin SS (1990). Recall bias in epidemiologic studies. J Clin Epidemiol 43:87–91. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, et al. (2009). International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20:525–531. Lang W, Borrusch H, Bauer L (1988). Occult carcinomas of the thyroid. Evaluation of 1020 sequential autopsies. Am J Clin Pathol 90...

UNLABELLED The aim of this report is to describe a fortuitely discovered association between parathyromatosis and papillary thyroid microcarcinoma. CASE DESCRIPTION A 56-year-old woman presented with a pyelic relapsed stone, bone pains, neurovegetative com-plaints and iPTH = 348 ng/l as manifestations of recurrent primary hyperparathyroidism after a right inferior parathyroid adenoma exeresis...

Objectives. Thyroid carcinomas incidence, in particular papillary variants, is increasing. These cancers are generally considered to have excellent prognosis, and papillary microcarcinomas are usually noninvasive. Many prognostic histopathology factors have been described to guide therapeutic decisions. Most patients are treated with total thyroidectomy without radioiodine treatment or partial ...

Introduction Thyroid papillary carcinoma represents 75% of all thyroid cancer cases. It is more prevalent in the young and middle age group of patients. Distant metastases occur in 10% of cases. Metastases to lymph nodes can be the first sign of microcarcinoma. This is a case report where thrombophlebitis of popliteal vein and pulmonary embolic disease appeared to be the first manifestation of ...

The thyroid cancer is a rare oncological entity, representing no more than 1% of all human malignant neoplasms. Recently, it has been demonstrated a sharp increase in incidence of differentiated thyroid carcinoma, equally occurring in both sexes. So far, multiple genetic alterations have been identified in differentiated thyroid carcinoma, leading to investigate the clinical utility of genetic ...